Analysts are weighing in on e-commerce powerhouse eBay Inc (NASDAQ:EBAY), pharmaceutical company Ascendis Pharma (NASDAQ:ASND), and aerospace concern Boeing Co (NYSE:BA). Here's a quick roundup of today's bullish brokerage notes on shares of EBAY, ASND, and BA.
Benchmark raised its EBAY price target to $45 from $40, but at last check, the stock was trading 0.3% lower at $38.13. The online auction site operator is cooling its heels after touching a record high of $38.87 on Wednesday, and EBAY currently boasts a healthy year-to-date gain of more than 28%.
A few recent price-target hikes aside, analysts are generally skeptical toward eBay. Out of 24 brokerage firms following the stock, 15 maintain a "hold" or "strong sell" rating. If any of these skeptics follow Benchmark's lead and issue bullish notes in response to the equity's rally to new highs, it could draw more buyers to the table for EBAY.
Credit Suisse raised its price target on ASND to $50 from $30, and Wedbush issued a hike to $65 from $36, after a failed late-stage trial for rival drugmaker Versartis (VSAR) -- with Wedbush analyst Liana Moussatos calling the setback "game over" for VSAR. While VSAR has plummeted 86% to trade at $2.97, Ascendis shares are up 35.1% at $37.48 -- and earlier set a new record high of $42, placing former round-number resistance at $30 firmly in the rearview.
Ahead of this positive news for ASND, analysts were already upbeat on the stock. Among the five analysts tracking the biopharma name, four maintain "strong buy" ratings.